VANCOUVER, BC–(Marketwired – January 08, 2018) – EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) (“EnWave”, or the “Company”) announced today that it has signed a Technology Evaluation and License Option Agreement (the “TELOA”) with Seven Seas Fish Company Limited (“Seven Seas”), a leading Canadian seafood manufacturer and international distributor.
The TELOA grants Seven Seas an exclusive six-month term to evaluate the use of Radiant Energy Vacuum (“REV™”) technology for the production of high-value, premium fin fish and other seafood snacks in British Columbia, Canada. A small-scale REV™ machine will be installed at Seven Seas’ facility in February 2018, which will trigger the commencement of the exclusive term.
Prior to signing the TELOA, EnWave and Seven Seas conducted several product development tests at the Company’s pilot plant that yielded positive results. REV™ technology has proven to work effectively in the dehydration of salmon, prawns, lobster, crab, scallops, mussels, oysters, sea cucumbers and other various seafood products.
About Seven Seas Fish
Seven Seas is a fish company that processes and distributes fresh, frozen and value added seafoods to a wide array of customer types in Canada and around the world. Full seafood distribution to retail, food service and wholesale distributors and a growing smoked and valued added line of sustainable, high quality seafoods. It sources seafood locally buying directly from fishers, but also globally buying from processors in several different countries. The company was founded in 1967 with its head office in Richmond, British Columbia, Canada. Seven Seas is a proven industry leader. For more information please visit www.7seas.ca.
EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (“REV™”) — an innovative, proprietary method for the precise dehydration of organic materials. REV™ technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, legal cannabis and pharmaceutical sectors. EnWave’s strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV™ technology. The company has signed over twenty royalty-bearing licenses to date, opening up eight distinct market sectors for commercialization of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.
EnWave has introduced REV™ as the new dehydration standard in the food and biological material sectors: faster and cheaper than freeze drying, with better end product quality than air drying or spray drying. EnWave currently has three commercial REV™ platforms:
1. nutraREV® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour;
2. powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and
3. quantaREV® which is used for continuous, high-volume low-temperature drying.
An additional platform, freezeREV®, is being developed as a new method to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies. More information about EnWave is available at www.enwave.net.
Dr. Tim Durance
President & CEO
Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management’s expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company’s strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
John Budreski, Executive Chairman at +1 (416) 930-0914
Brent Charleton, Senior Vice President, Sales and Business Development at +1 (778) 378-9616
Deborah Honig, Corporate Development, Adelaide Capital Markets at + 1 (647) 203-8793